Matches in Wikidata for { <http://www.wikidata.org/entity/Q53069236> ?p ?o ?g. }
- Q53069236 description "2018 nî lūn-bûn" @default.
- Q53069236 description "2018年の論文" @default.
- Q53069236 description "2018年学术文章" @default.
- Q53069236 description "2018年学术文章" @default.
- Q53069236 description "2018年学术文章" @default.
- Q53069236 description "2018年学术文章" @default.
- Q53069236 description "2018年学术文章" @default.
- Q53069236 description "2018年学术文章" @default.
- Q53069236 description "2018年學術文章" @default.
- Q53069236 description "2018年學術文章" @default.
- Q53069236 description "2018年學術文章" @default.
- Q53069236 description "2018年學術文章" @default.
- Q53069236 description "2018年學術文章" @default.
- Q53069236 description "2018년 논문" @default.
- Q53069236 description "article científic" @default.
- Q53069236 description "article scientific" @default.
- Q53069236 description "article scientifique" @default.
- Q53069236 description "articol științific" @default.
- Q53069236 description "articolo scientifico" @default.
- Q53069236 description "artigo científico" @default.
- Q53069236 description "artigo científico" @default.
- Q53069236 description "artigo científico" @default.
- Q53069236 description "artikel ilmiah" @default.
- Q53069236 description "artikull shkencor" @default.
- Q53069236 description "artikulong pang-agham" @default.
- Q53069236 description "artykuł naukowy" @default.
- Q53069236 description "artículo científico publicado en 2018" @default.
- Q53069236 description "artículu científicu" @default.
- Q53069236 description "bilimsel makale" @default.
- Q53069236 description "bài báo khoa học" @default.
- Q53069236 description "naučni članak" @default.
- Q53069236 description "scienca artikolo" @default.
- Q53069236 description "scientific article published in January 2018" @default.
- Q53069236 description "scientific article published in January 2018" @default.
- Q53069236 description "scientific article published in January 2018" @default.
- Q53069236 description "teaduslik artikkel" @default.
- Q53069236 description "tieteellinen artikkeli" @default.
- Q53069236 description "tudományos cikk" @default.
- Q53069236 description "vedecký článok" @default.
- Q53069236 description "vetenskaplig artikel" @default.
- Q53069236 description "videnskabelig artikel" @default.
- Q53069236 description "vitenskapelig artikkel" @default.
- Q53069236 description "vitskapeleg artikkel" @default.
- Q53069236 description "vědecký článek" @default.
- Q53069236 description "wetenschappelijk artikel" @default.
- Q53069236 description "wissenschaftlicher Artikel" @default.
- Q53069236 description "επιστημονικό άρθρο" @default.
- Q53069236 description "мақолаи илмӣ" @default.
- Q53069236 description "наукова стаття, опублікована в січні 2018" @default.
- Q53069236 description "научна статия" @default.
- Q53069236 description "научная статья" @default.
- Q53069236 description "научни чланак" @default.
- Q53069236 description "научни чланак" @default.
- Q53069236 description "מאמר מדעי" @default.
- Q53069236 description "مقالة علمية نشرت في يناير 2018" @default.
- Q53069236 description "জানুয়ারি ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q53069236 description "บทความทางวิทยาศาสตร์" @default.
- Q53069236 description "სამეცნიერო სტატია" @default.
- Q53069236 name "Sustained reductions in migraine days, moderate-to-severe headache days and days with acute medication use for HFEM and CM patients taking fremanezumab: Post-hoc analyses from phase 2 trials." @default.
- Q53069236 name "Sustained reductions in migraine days, moderate-to-severe headache days and days with acute medication use for HFEM and CM patients taking fremanezumab: Post-hoc analyses from phase 2 trials." @default.
- Q53069236 type Item @default.
- Q53069236 label "Sustained reductions in migraine days, moderate-to-severe headache days and days with acute medication use for HFEM and CM patients taking fremanezumab: Post-hoc analyses from phase 2 trials." @default.
- Q53069236 label "Sustained reductions in migraine days, moderate-to-severe headache days and days with acute medication use for HFEM and CM patients taking fremanezumab: Post-hoc analyses from phase 2 trials." @default.
- Q53069236 prefLabel "Sustained reductions in migraine days, moderate-to-severe headache days and days with acute medication use for HFEM and CM patients taking fremanezumab: Post-hoc analyses from phase 2 trials." @default.
- Q53069236 prefLabel "Sustained reductions in migraine days, moderate-to-severe headache days and days with acute medication use for HFEM and CM patients taking fremanezumab: Post-hoc analyses from phase 2 trials." @default.
- Q53069236 P1433 Q53069236-90B56C00-5524-4880-8884-DA8C964140B1 @default.
- Q53069236 P1476 Q53069236-D3C16CF8-816A-4B0A-B430-260EF49B6058 @default.
- Q53069236 P2093 Q53069236-06D46B61-3DAD-49AB-8529-BADEA78CB143 @default.
- Q53069236 P2093 Q53069236-957C161B-72C8-4377-A8A7-D71078776970 @default.
- Q53069236 P2093 Q53069236-A2D0E972-0B86-41B4-B297-14BEECB2A448 @default.
- Q53069236 P2093 Q53069236-CDA4A39F-AC03-43E3-9276-B0573860B185 @default.
- Q53069236 P304 Q53069236-A80CD7BA-2625-43F2-8573-862443F016C4 @default.
- Q53069236 P31 Q53069236-C8B23374-7F4D-40ED-A55F-9F1AE8AD0DFC @default.
- Q53069236 P356 Q53069236-A10AB31E-3C13-4AEB-8C10-02A62B713665 @default.
- Q53069236 P407 Q53069236-A0504F7D-576A-4181-9A39-D68C457428EF @default.
- Q53069236 P50 Q53069236-8D3B73FD-9976-4E85-8F76-CC15B7924916 @default.
- Q53069236 P50 Q53069236-9C702F96-0068-4096-9BD3-95BF66324032 @default.
- Q53069236 P577 Q53069236-D6D7E418-A185-48CD-ADBE-4DFAF964E04D @default.
- Q53069236 P698 Q53069236-0811CD5D-981D-446F-81D9-B6774DC5D98E @default.
- Q53069236 P921 Q53069236-4BA092C4-E3F0-4EDF-B52E-428165E1954A @default.
- Q53069236 P921 Q53069236-C18D88A6-EFB0-49CB-9189-0ADF94EB9202 @default.
- Q53069236 P921 Q53069236-CA56F7C5-08E9-4D7F-9DF8-FAB8A5710585 @default.
- Q53069236 P356 0333102418772585 @default.
- Q53069236 P698 29722276 @default.
- Q53069236 P1433 Q5063251 @default.
- Q53069236 P1476 "Sustained reductions in migraine days, moderate-to-severe headache days and days with acute medication use for HFEM and CM patients taking fremanezumab: Post-hoc analyses from phase 2 trials." @default.
- Q53069236 P2093 "Ernesto Aycardi" @default.
- Q53069236 P2093 "Mirna McDonald" @default.
- Q53069236 P2093 "Pippa S Loupe" @default.
- Q53069236 P2093 "Rashmi B Halker Singh" @default.
- Q53069236 P304 "333102418772585" @default.
- Q53069236 P31 Q13442814 @default.
- Q53069236 P356 "10.1177/0333102418772585" @default.
- Q53069236 P407 Q1860 @default.
- Q53069236 P50 Q78653335 @default.
- Q53069236 P50 Q78768282 @default.
- Q53069236 P577 "2018-01-01T00:00:00Z" @default.
- Q53069236 P698 "29722276" @default.
- Q53069236 P921 Q39048381 @default.
- Q53069236 P921 Q42824440 @default.